NCT06481111|Recruiting
Loading search results
Sponsor study identifier
observational
1,000
1 country
1
Study Start
July 10, 2024
Actual (reported)Primary Completion
December 30, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 1, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The Endocrinology Unit of the IRCCS San Raffaele Hospital is dedicated to establishing a prospective single-center registry with data from patients undergoing vitamin D supplementation, initiating their first visit to the outpatient unit until December 2029. 1000 patients will be enrolled, aligning with the unit's recent patient influx for hypovitaminosis D. The registry's goal is to assess the epidemiological trend, identify risk factors, and evaluate the diagnostic and therapeutic clinical management strategies for hypovitaminosis D. It will involve collecting clinical, laboratory, and historical data during outpatient visits, adhering to the standard diagnostic and therapeutic protocols for endocrine-metabolic diseases. This data collection is expected to continue for a duration of ten years.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 1, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 4, 2024
Actual (reported)July 1, 2024
Actual (reported)July 10, 2024
Actual (reported)December 30, 2029
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 1, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Change from baseline of data in outpatient accessing Endocrinology Unit of the IRCCS San Raffaele Hospital for endocrine-metabolic diseases who are on supplementary treatment with vitamin D.
The main outcome of the study is to assess the prevalence changes of major comorbidities and their complications including cardiovascular diseases, diabetes, cancer, and osteoporosis, during the study-period in relation to the use and characteristics of vitamin D supplementation, in order to evaluate the potential influence of vitamin D use on patient's outcomes. The pathological conditions will be diagnosed according to current major guidelines and clinical practice.
10 years
observational design
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
outpatient clinics who will access of the Endocrinology Unit of the IRCCS San Raffaele Hospital for endocrine-metabolic diseases and who are on supplementary treatment with vitamin D until December 2029
IRCCS Ospedale San Raffaele
Milan, 20132, Italy
Luigi di Filippo, MD
IRCCS San Raffaele
First Submitted
June 4, 2024
First Posted
July 1, 2024
Study Start
July 10, 2024
Actual (reported)Primary Completion
December 30, 2029
EstimatedThe Effectiveness of a Weight-dependent Algorithm for Dosing Vitamin D.
Contact the study team to confirm eligibility.
Planned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 1, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
April 8, 2026
Record last verified: 2026-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: